SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-005286
Filing Date
2015-11-10
Accepted
2015-11-10 16:10:53
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 669408
2 ex4-3.htm EX-4.3 29557
3 ex10-2.htm EX-10.2 43555
4 ex31-1.htm EX-31.1 15715
5 ex32-1.htm EX-32.1 5525
  Complete submission text file 0001493152-15-005286.txt   3810884

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE lixt-20150930.xml EX-101.INS 583405
7 XBRL SCHEMA FILE lixt-20150930.xsd EX-101.SCH 59130
8 XBRL CALCULATION FILE lixt-20150930_cal.xml EX-101.CAL 34615
9 XBRL DEFINITION FILE lixt-20150930_def.xml EX-101.DEF 188271
10 XBRL LABEL FILE lixt-20150930_lab.xml EX-101.LAB 373358
11 XBRL PRESENTATION FILE lixt-20150930_pre.xml EX-101.PRE 245216
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-51476 | Film No.: 151219052
SIC: 2834 Pharmaceutical Preparations